Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $202.7 million.

  • Accendra Health's Receivables - Net fell 6936.04% to $202.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.7 million, marking a year-over-year decrease of 6936.04%. This contributed to the annual value of $218.3 million for FY2024, which is 6351.57% down from last year.
  • Accendra Health's Receivables - Net amounted to $202.7 million in Q3 2025, which was down 6936.04% from $196.4 million recorded in Q2 2025.
  • Over the past 5 years, Accendra Health's Receivables - Net peaked at $775.8 million during Q1 2022, and registered a low of $196.4 million during Q2 2025.
  • For the 5-year period, Accendra Health's Receivables - Net averaged around $623.9 million, with its median value being $681.6 million (2021).
  • Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 1655.91% in 2021, then crashed by 7035.54% in 2025.
  • Over the past 5 years, Accendra Health's Receivables - Net (Quarter) stood at $681.6 million in 2021, then grew by 12.02% to $763.5 million in 2022, then fell by 21.64% to $598.3 million in 2023, then plummeted by 63.52% to $218.3 million in 2024, then dropped by 7.12% to $202.7 million in 2025.
  • Its last three reported values are $202.7 million in Q3 2025, $196.4 million for Q2 2025, and $580.2 million during Q1 2025.